瘢痕疙瘩切除术后辅助放疗:台湾初步经验
本文回顾台湾单中心2013至2016年接受瘢痕疙瘩切除联合放疗的连续病例,平均随访28个月,总复发率32%。仅JSW分类评分独立预测复发风险(OR=1.305,P=0.02),VSS与JSW评分均与复发相关。提示该方案在台湾人群可行有效,需优化生物等效剂量以改善局部控制。
要点
- 瘢痕疙瘩切除术后辅助放疗总复发率32%,平均随访28个月。
- JSW分类评分独立预测复发风险(OR=1.305,P=0.02)。
- VSS与JSW评分均与复发相关(相关系数0.529和0.54)。
核心结论
- 初步证据支持台湾人群瘢痕疙瘩切除术后辅助放疗可行且有效。
- 建议考虑更精细的生物等效剂量以改善局部控制。
研究设计与样本
- 单中心回顾性病历回顾,纳入2013至2016年连续接受手术切除联合放疗的瘢痕疙瘩患者。
- 收集已报道的危险因素进行结局分析,使用VSS和JSW瘢痕量表评估与复发的相关性。
主要发现
- 总复发率为32%,平均随访28个月。
- 独立危险因素因结局变量不同而异,仅JSW分类评分独立预测复发风险(OR=1.305,P=0.02)。
- VSS与JSW系统均与瘢痕疙瘩复发良好相关(相关系数0.529和0.54;P=0.0437和0.0165)。
关键数值与推荐
- JSW分类评分每增加1分,复发风险OR=1.305(P=0.02)。
- VSS与复发相关系数0.529(P=0.0437),JSW评分与复发相关系数0.54(P=0.0165)。
临床怎么用
- 对台湾人群瘢痕疙瘩切除术后可考虑辅助放疗,并以JSW分类评分评估复发风险。
- 放疗剂量方案需进一步优化生物等效剂量以平衡局部控制与安全性。
局限性
- 单中心回顾性研究,样本量未报告。
- 为初步经验报告,随访时间平均28个月,长期结局未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical excision with adjuvant radiotherapy has gained attention as an effective treatment of keloid. The Asian population is challenged with a high incidence of keloid occurrence with a specific genetic predominance. The annual reported incidence of new keloid cases in Taiwan is around 30,000, but the disease control rate and effectiveness by means of surgical excision with adjuvant radiotherapy is not yet clear. METHODS: A retrospective chart review of the included consecutive keloid patients receiving surgical excision and radiotherapy was performed from 2013 to 2016 in a single institute. The reported risk factors were collected to investigate according to the outcome analysis. The Vancouver Scar Scale and the Japan Scar Workshop (JSW) Scar Scale were used to evaluate the correlation with keloid recurrence. RESULTS: In this series, the overall recurrence rate was 32%, reported with an average follow-up of 28 months. Independent risk factors varied according to the different outcome variables. Only JSW classification score independently predicted the risk of keloid recurrence (odds ratio, 1.305; P = 0.02). Both the Vancouver Scar Scale and the JSW system showed a good correlation with keloid recurrence (correlation efficiency, 0.529 and 0.54; P = 0.0437 and 0.0165, respectively). CONCLUSIONS: This preliminary report revealed convincing evidence of feasibility and effectiveness of applying adjuvant radiotherapy after keloid excision in the Taiwanese population. A more delicate biological equivalent dose of radiotherapy with an effective local control should be considered to improve the final outcome.
引用
- Hsueh WT, Hung KS, Chen YC, et al. Adjuvant Radiotherapy After Keloid Excision: Preliminary Experience in Taiwan. Ann Plast Surg. 2019. PMID: 30461461. doi:10.1097/SAP.0000000000001728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。